🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Xeris Biopharma Holdings, Inc. (XERS)
NASDAQ: XERS · Real-Time Price · USD
16.69
+0.07 (0.42%)
Nov 20, 2026, 10:01 AM EST - Market open

Xeris Biopharma Holdings Revenue

Xeris Biopharma Holdings had revenue of $107.23M in the quarter ending September 30, 2026, with 44.16% growth. This brings the company's total for the last twelve months to $368.26M, up 38.37% year-over-year. In the year 2025, Xeris Biopharma Holdings had annual revenue of $291.85M with 43.72% growth. That makes Xeris Biopharma Holdings the 13,173rd largest company in the world by revenue and 2,481st in the United States.

Revenue (ttm)
$368.26M
Revenue Growth
+38.37%
P/S Ratio
8.25
Revenue / Employee
$846,572
Employees
435
Market Cap
3.05B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025291.85M88.78M43.72%
Dec 31, 2024203.07M39.16M23.89%
Dec 31, 2023163.91M53.67M48.68%
Dec 31, 2022110.25M60.66M122.32%
Dec 31, 202149.59M29.16M142.67%
Dec 31, 202020.44M17.71M650.73%
Dec 31, 20192.72M299.00K12.34%
Dec 31, 20182.42M867.00K55.72%
Dec 31, 20171.56M481.00K44.74%
Dec 31, 20161.08M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.